Close Menu

NEW YORK (GenomeWeb) — Roche has received regulatory clearance to finalize its acquisition of Kapa Biosystems, the company announced this week. Wilmington, Massachusetts-based Kapa develops genomics tools. Its acquisition will add to Roche's NGS portfolio by building on its existing NGS target enrichment products, Roche said. Terms of the deal were undisclosed.


Danaher announced this week that its board of directors has approved a quarterly share dividend of $.135 per share, which will be paid on Jan. 29, 2016 to holders of record on Dec. 21, 2015.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports that recent proposed changes to the US National Science Foundation have raised concerns about a shift away from the agency's focus on basic research.

Noel Rose, the "father of autoimmunity," has died at 92, the Washington Post reports.

According to CNN, Legionella was discovered in buildings leased by the Centers for Disease Control and Prevention as they reopened following coronavirus pandemic-related closures.

In PLOS this week: genetic analysis of malaria parasite populations in Southeast Asia, genomic surveillance of yellow fever virus in São Paulo, and more.